News

Findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes and chronic kidney disease, were presented at EASD 2024.

New analysis from the SURPASS-4 trial identifies crucial factors for maintaining blood glucose control and weight loss with tirzepatide in patients with Type 2 diabetes.

A key study presented at EASD 2024 highlights that rapidly managing blood sugar in pregnant women with gestational diabetes reduces the risk of obesity in their children.

A recent study conducted in South Korea has found that quitting smoking can significantly reduce the risk of developing hidradenitis suppurativa.

A recent study has highlighted the potential of AI to improve radiology workflows by automating the identification of unremarkable chest radiographs.

A new predictive model identifies key risk factors for endometrial hyperplasia and cancer in patients with recurrent abnormal uterine bleeding

New research from DDW 2024 shows older adults with inflammatory bowel disease treated with advanced therapies may face a slightly increased risk of infection.

Metabolic bariatric surgery offers substantial protective benefits for patients with chronic kidney disease, Type 2 diabetes, and obesity, according to new research.